Xingkong Capital
Overview
Xingkong Capital is a private equity investment firm based in Chengdu, China, that focuses on investments in the pharmaceutical, life sciences, and healthcare sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Dongfang Lue | Jan 2017 | Private Placement | Co-investor |
| Chengdu NewRT Medical Technology | Mar 2024 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Xingkong Capital based?
Xingkong Capital is headquartered in Chengdu, China.
When was Xingkong Capital founded?
Xingkong Capital was founded in 2016.
How many portfolio companies does Xingkong Capital have?
Xingkong Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Xingkong Capital's portfolio?
Portfolio companies visible on Caplight include Dongfang Lue, Chengdu NewRT Medical Technology.
What was Xingkong Capital's most recent investment shown here?
Xingkong Capital's most recent investment in this portfolio sample was in Chengdu NewRT Medical Technology in 2024.
What sectors does Xingkong Capital focus on?
Xingkong Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming.
What company stages does Xingkong Capital focus on?
Xingkong Capital typically invests at the Mid stage.
What is Xingkong Capital's AUM?
Xingkong Capital's assets under management are estimated between $276.5M and $414.9M.